A new study has found that most patients with mild COVID-19 infections produce antibodies that persist and protect them from reinfection for up to six months.
from NDTV News - Latest https://ift.tt/2YP0zom
from NDTV News - Latest https://ift.tt/2YP0zom
Comments
Post a Comment